Urate transport in the proximal tubule: in vivo and vesicle studies.
The transport of urate in the mammalian nephron is largely confined to the proximal tubule. Depending on the species, net reabsorption or net secretion is observed. The rat, like the human and the mongrel dog, demonstrates net reabsorption of urate and has been the most extensively studied species. The unidirectional reabsorption and secretion of urate in the rat proximal tubule occur via a passive and presumably paracellular route and by a mediated transcellular route. The reabsorption of urate, and possibly its secretion, can occur against an electrochemical gradient. A variety of drugs and other compounds affect the reabsorption and secretion of urate. The effects of these agents depend on their site of application (luminal or blood), concentration, and occasionally their participation in transport processes that do not have affinity for urate. Recent studies with renal brush border and basolateral membrane vesicles from the rat and brush border vesicles from the dog have determined the mechanisms for urate transport across the luminal and antiluminal membranes of the proximal tubule cell. Brush border membrane vesicles contain an anion exchanger with affinity for urate, hydroxyl ion, bicarbonate, chloride, lactate, p-aminohippurate (PAH), and a variety of other organic anions. Basolateral membrane vesicles contain an anion exchanger with affinity for urate and chloride but not for PAH. Both membrane vesicle preparations also permit urate translocation by simple diffusion. A model for the transcellular reabsorption and secretion of urate in the rat proximal tubule is proposed. This model is based on the vesicle studies, and it can potentially explain the majority of urate transport data obtained with in vivo techniques.
D000042:Absorption; D000818:Animals; D001485:Basement Membrane / Q000378:metabolism; D001639:Bicarbonates / Q000378:metabolism; D001693:Biological Transport, Active; D002712:Chlorides / Q000378:metabolism; D004285:Dogs; D006801:Humans; D006878:Hydroxides; D017665:Hydroxyl Radical; D007231:Infant, Newborn; D007536:Isomerism; D007687:Kidney Tubules, Proximal / Q000378:metabolism*; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D008871:Microvilli / Q000378:metabolism; D008954:Models, Biological; D011339:Probenecid / Q000008:administration & dosage / Q000494:pharmacology; D011718:Pyrazinamide / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D013045:Species Specificity; D014527:Uric Acid / Q000378:metabolism*; D010130:p-Aminohippuric Acid / Q000378:metabolism
D001639:Bicarbonates; D002712:Chlorides; D006878:Hydroxides; D007773:Lactates; D014527:Uric Acid; D011718:Pyrazinamide; C005296:pyrazinoic acid; D017665:Hydroxyl Radical; D019344:Lactic Acid; D011339:Probenecid; D010130:p-Aminohippuric Acid